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Abstract 
 
Background: Two major sources of heterogeneity of mood disorders that have been demonstrated in 
clinical, family and genetic studies are the mood disorder subtype (i.e. bipolar (BPD) and major 
depressive disorder (MDD)) and age of onset of mood episodes. Using a prospective high-risk study 
design, our aims were to test the specificity of the parent-child transmission of BPD and MDD and to 
establish the risk of psychopathology in offspring in function of the age of onset of the parental 
disorder.  
Methods: Clinical information was collected on 208 probands (n=81 with BPD, n=64 with MDD, 
n=63 medical controls) as well as their 202 spouses and 372 children aged 6-17 years at study entry. 
Parents and children were directly interviewed every 3 years (mean duration of follow-up = 10.6 
years). Parental age of onset was dichotomized at age 21. 
Results: Offspring of parents with early onset BPD entailed a higher risk of BPD HR=7.9(1.8-34.6) 
and substance use disorders HR=5.0(1.1-21.9) than those with later onset and controls. Depressive 
disorders were not significantly increased in offspring regardless of parental mood disorder subtype or 
age of onset.  
Limitations: limited sample size, age of onset in probands was obtained retrospectively, age of onset 
in co-parents was not adequately documented, and a quarter of the children had no direct interview. 
Conclusions: Our results provide support for the independence of familial aggregation of BPD from 
MDD and the heterogeneity of BPD based on patterns of onset. Future studies should further 
investigate correlates of early versus later onset BPD.  
 
Key Words: mania; age of onset; family aggregation; high-risk study; major depression; substance 
use disorders.  
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1. Introduction 
 
The lack of successful identification of genetic markers underlying mood disorders has led to 
increasing scrutiny of sources of heterogeneity of the mood disorder spectrum (Kennedy et al., 2015; 
Major Depressive Disorder Working Group of the Psychiatric et al., 2013). Two of the major sources 
of heterogeneity of bipolar disorder are the subtypes of mood disorders, particularly bipolar disorder 
(BPD) and and major depressive disorder (MDD), and the age of onset of mood disorders (Etain et al., 
2012; Geoffroy et al., 2013). Our recent evidence for the independence of familial transmission of 
BPD and MDD as well as their major components manic and major depressive episodes (Merikangas 
et al., 2014; Vandeleur et al., 2014) suggests that these mood disorder subtypes may represent distinct 
underlying continua rather than increasingly severe manifestations of a common underlying diathesis 
(Hickie, 2014). Studies of offspring of parents with BPD or MDD have confirmed elevated risks of 
BPD (Axelson et al., 2015; Birmaher et al., 2009; Duffy et al., 2010; Henin et al., 2005; Nurnberger et 
al., 2011) and of MDD (Hirshfeld-Becker et al., 2012) among offspring, but the independence of the 
familial aggregation of the two mood disorder subtypes could not be appropriately tested given the 
absence of controlled studies that simultaneously included parents with BPD and MDD.  
There have also been numerous studies of subtypes within BPD (Phillips and Kupfer, 2013) and 
MDD (Lamers et al., 2013), but to date, the only consistent subtype that has been demonstrated in 
family studies of adults and high risk studies of offspring is early age of onset of mood disorders. 
Family studies have documented elevated rates of mood disorders among adult relatives (Bellivier et 
al., 2003; Grigoroiu-Serbanescu et al., 2001; Grigoroiu-Serbanescu et al., 2014; Schurhoff et al., 2000; 
Somanath et al., 2002), siblings (Lin et al., 2006), and offspring (Oquendo et al., 2013) of probands 
with BPD with an early onset as compared to those with a later onset. Two studies however in adult 
relatives (Schulze et al., 2006) and high-risk offspring (Goldstein et al., 2010) did not find the risk of 
BPD to be determined by parental onset, reinforcing a lack of conclusiveness regarding the pertinence 
of this subtype of BPD. Regarding MDD, one study observed higher rates of MDD among the 
relatives of adult MDD probands with an age at onset before age 20 compared to those of probands 
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with a later onset or controls (Weissman et al., 1984), whereas another study that followed probands 
from childhood to adulthood found the rates of MDD to be independent of the age of onset of the 
proband’s MDD (Harrington et al., 1997). Recent large scale collaborative genetic studies of MDD 
have also shown that there is increased single nucleotide polymorphism (SNP)-based heritability of 
early onset MDD (Ferentinos et al., 2015).  
To date, no controlled prospective study that included probands with both BPD and MDD has 
examined the incidence of mood disorder subtypes and other psychopathology in offspring by the age 
at onset of parental disorders. This design minimizes recall bias regarding the age of onset and permits 
evaluation of the sequence of onset of mood disorder subtypes and that of other types of 
psychopathology. Accordingly, using the high-risk design, the aims of the present study were to:  
1) Test the specificity of the parent-child transmission of BPD and MDD and establish the 
cumulative risk of non-mood psychopathology in offspring; 
2) Establish the risk of mood and non-mood psychopathology in offspring as a function of 
parental mood disorder age of onset. Age of onset was stratified at age 21 based on prior 
evidence (Etain et al., 2012; Geoffroy et al., 2013; Grigoroiu-Serbanescu et al., 2014) for age 
20-21 as an early age of onset cut-off. 
 
2. Methods 
2.1. Sample 
The sample stemmed from a large family study of mood disorders conducted in the French-speaking 
part of Switzerland (Vandeleur et al., 2014). Probands with BPD and MDD were consecutively 
recruited from the inpatient and outpatient facilities of the psychiatric departments of Lausanne and 
Geneva between 1996 and 2004. Inclusion criteria for mood disorder probands were: (1) lifetime 
bipolar-I (n=53), bipolar-II (n=10), schizoaffective bipolar disorder (n=18), or MDD (n=64), 2) age 
between 18 and 65 years, 3) ability to speak sufficient French or English to complete the diagnostic 
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interview, and (4) availability of diagnostic data on one or more offspring (aged 6.0 to 17.9 years at 
study intake) from a minimum of two assessments with at least one direct interview. Comparison 
probands (n=63) were recruited from the orthopedic departments of Lausanne and Geneva. Inclusion 
criteria for the comparison probands were: (1) the absence of a lifetime mood or psychotic disorder, 2) 
age between 18 and 65 years, 3) ability to speak sufficient French or English to complete the 
diagnostic interview, and (4) the same inclusion criterion for offspring as that of the mood disorder 
cases. The choice of recruiting medical controls rather than subjects from the general population was 
motivated by our goal to create a comparison group that was selected from the same clinical settings as 
the probands with affective disorders. The specific choice of recruiting in orthopedic rather than other 
medical facilities was motivated by the fact that orthopedic problems are less likely to be induced by a 
psychiatric problem than other medical problems (e.g. cardiovascular or metabolic problems) and that 
a relatively large proportion of orthopedic patients are in the same age range as psychiatric patients 
(18-65 years). 
An effort was made to interview all co-parents of biological offspring. Data on 202 co-parents 
were available of whom 60% had been directly interviewed. Parents and offspring were invited to take 
part in follow-up assessments at predetermined ages of the offspring (7, 10, 13, 16, 19, 22, 25, 28, 31 
and 34 years). The average number of assessments of the 372 offspring was 4.2 (s.d.=1.3; range: 2-7) 
with a mean duration of 10.6 years follow-up (s.d.: 3.6). Three quarters of the assessments included 
direct interviews. The mean offspring age at the first assessment was 10.0 years (s.d.=4.3 years) and 
20.6 years (s.d.=5.6 years) at the last assessment.  
2.2. Procedures 
Diagnostic methods for this study were also described in previous publications (Vandeleur et 
al., 2012). Information on parents and adult offspring was obtained using the semi-structured 
Diagnostic Interview for Genetic Studies (DIGS) (Nurnberger et al., 1994) and offspring younger than 
18 years were directly interviewed using a French translation of the modified version of the Kiddie-
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Schedule for Affective Disorders and Schizophrenia (K-SADS-E) (Orvaschel et al., 1982). In addition 
to direct interviews, information on children and parents was systematically elicited from all 
participants who were at least 15 years old using the Family History-Research Diagnostic Criteria 
(FH-RDC) (Andreasen et al., 1977). The validity and French translation of the DIGS (Berney et al., 
2002; Leboyer et al., 1995; Preisig et al., 1999),  the reliability of the K-SADS-E (Chambers et al., 
1985; Gammon et al., 1983; Orvaschel et al., 1982; Vandeleur et al., 2012), and the validity of the FH-
RDC (Rothen et al., 2009; Rougemont-Buecking et al., 2008; Vandeleur et al., 2008; Vandeleur et al., 
2015) have been extensively tested. Interviewers were required to be masters-level psychologists and 
were trained over a two-month period. They were blind to the disease status of the other family 
members. Each interview was reviewed by a senior psychologist. 
Diagnoses were made over lifetime using a best-estimate procedure (Leckman et al., 1982), 
which relied on the combination of information from direct interviews, family history report(s), and 
medical records. Diagnostic algorithms for “Other Specified Bipolar and Related Disorders” 
(OSBARD) and “Other Specified Depressive Disorders” (OSDD) were defined according to the DSM-
5 to assign subthreshold diagnoses. Non-mood disorders were defined according to the DSM-IV. The 
SES of the families was based on income and education level of both spouses of the household 
(Hollingshead, 1975). The severity of probands’ disorders over lifetime was assessed using the DSM-
IV Global Assessment of Functioning (GAF) scale, which provides an assessment of the probands’ 
level of psychological, social and occupational functioning.  
This research project was approved by the local institutional review board. All participants 
gave written informed consent for their own participation prior to the assessments. In addition, parents 
gave written consent for the participation of their offspring younger than 18 years. 
2.3. Data analysis  
Between-group analyses were performed using the chi-square, t-tests or ANOVA and using 
multilevel models for non independent data in offspring. Hazard ratios were computed using serially 
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adjusted shared gamma frailty models for survival data (Rondeau et al., 2012) to assess the impact of 
the probands’ disorder on incidence of offspring disorders. The offspring of probands with mood 
disorders were compared to the offspring of controls. These models account for the lack of 
independence of the observations (varying number of offspring across families). Model 1 was adjusted 
for sex, age, and the number of information points in offspring as well as the probands’ age and the 
SES. Model 2 was further adjusted for probands’ comorbid anxiety disorders (generalized anxiety 
disorder, panic disorder, social phobia, agoraphobia), SUD (alcohol and drug abuse or dependence) 
and behavioral disorders that mainly occurred during childhood (conduct, oppositional defiant 
disorder, and attention-deficit hyperactivity disorder). Model 3 was further controlled for the effects of 
the co-parents’ disorder(s). One hundred multiple imputations were performed using the MissForest 
procedure based on random forests (Stekhoven and Buhlmann, 2012) to adjust for missing data in co-
parents (24 diagnoses of SUD, mood and anxiety disorders and 111 diagnoses of behavioral 
disorders). In an additional model, we adjusted for disorder severity according to the GAF score. 
Moreover, in order to verify that our results were not biased by the inclusion of 35 offspring of 18 
probands with schizoaffective bipolar disorder rather than BPD, we also ran the models excluding the 
offspring of probands with schizoaffective disorder. 
Age of onset in parents was based on the age of the first full mood episode described (mania, 
hypomania or major depressive episode (MDE)). In the case of missing data or ambiguity ages of 
onset were based on the medical records where available. The ROC curve contrast estimation 
coefficient was used to validate the thresholds for the ability of probands’ age of onset to discriminate 
mood status in offspring. Measures of sensitivity, specificity and total accuracy were used as an 
indication of the optimal threshold (Fawcett, 2006). Using the thresholds that subdivided the probands 
into early versus later onset subtypes, cumulative risk estimates and hazard ratios were then 
established for offspring disorder outcomes using the same methodology as for the previous analyses. 
Early onset was defined as age 20-21 and younger and late onset was defined as age 22 and older. 
Analyses were conducted using the Statistical Analysis System, version 9.3 (SAS Institute, Inc., Cary, 
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NC, USA), and the statistical analyses environment R (R Core Team. R Foundation for Statistical 
Computing, Vienna, Austria. http://www.R-project.org/). 
We performed a power analysis (Hsieh and Lavori, 2000) using the powerSurvEpi package (R 
package version 0.0.9. http://CRAN.R-project.org/package=powerSurvEpi). The power of the model 
was calculated for each disorder in offspring in function of the proband’s disorder status. Regardless 
of the parental diagnostic status, the power to detect a difference between the offspring of affected 
parents and controls was >0.7 for HRs of at least 2.0 for any mood disorder, depressive spectrum 
disorders, MDD, anxiety disorders and separation anxiety disorder. For all other disorders, the power 
was only sufficient to detect associations with a HR of at least 3.0, whereas for bipolar disorders, only 
very strong associations could be detected. 
 
 
3. Results 
Table 1 reveals the characteristics of probands and offspring as a function of the proband’s 
diagnosis. About half the sample was male. Probands with mood disorders and controls differed with 
respect to marital status and lifetime history of anxiety disorders and substance use disorders (SUD) 
(p<0.001). Families of probands with MDD had the lowest socio-economic status (SES) (<0.01) and 
their offspring had the lowest age at the last follow-up and the lowest number of assessments. In 
addition, the spouses of probands with BPD (25.0%) or MDD (33.3%) reported SUD more frequently 
than those of controls (8.1%; Χ2
2
=11.8, p <0.01). 
INSERT TABLE 1 HERE 
Table 2 provides the cumulative incidence of offspring disorders as well as the results of the 
shared gamma frailty models. Four hazard ratios were significant until adjusted for probands’ 
comorbid and spouses’ disorders. The hazard ratios for: (1) offspring BPD, either any BPD (including 
subthreshold BPD) or bipolar-I and bipolar-II disorders combined of BPD probands were both 
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5.4(1.3,21.6) unadjusted and 2.8(0.6,12.9) adjusted; (2) risk of separation anxiety disorder (SAD) in 
the offspring of BPD probands were 1.9(1.1,3.3) unadjusted and 1.7(0.9,3.0) adjusted; (3) ADHD in 
the offspring of MDD probands were 2.1(1.1,4.2) unadjusted and 1.9(0.8,4.4) adjusted; (4) SUD in 
offspring of MDD probands were 2.9(1.1,7.9) unadjusted and 2.4(0.8,7.8) adjusted. The unadjusted 
association for SAD in offspring of MDD probands 2.9(1.6,5.1) remained significant in the models 
adjusted for probands’ comorbid 2.3(1.2,4.3) and spouses’ disorders 2.4(1.2,4.6). 
INSERT TABLE 2 HERE 
Among the 81 bipolar probands and 64 MDD probands, 31(38.3%) and 19(29.7%) 
respectively had a disorder that started before the age of 21 years. Mean age of bipolar probands with 
an early compared to late onset were 38.5 and 41.6, F=4.2, p<0.05, respectively. No significance was 
found between bipolar probands’ onset age and history of comorbid disorders or SES. Their children, 
however, were younger at the first (9.1 vs. 11.1 years, F=4.6, p<.05) and last interview (18.4 vs. 22.6 
years, F=10.8, p<.01) and had less assessments (3.8 vs. 4.5, F=4.3, p<.05) and interviews (2.8 vs. 3.6, 
F=6.2, p<.05). Early onset MDD probands were younger than those with a later onset (38.3 vs. 42.6 
years, F=4.5, p<.05). No significance was found between MDD probands’ onset age and history of 
comorbid disorders or SES.  Their children did not differ regarding age at the first or last interview, or 
the number of assessments and interviews. 
Table 3 provides the cumulative incidence of offspring disorders by age of onset as a function 
of probands’ mood disorder subtype. Also presented are hazard ratios from the serially adjusted shared 
gamma frailty models. In all models, the offspring of early onset BPD probands displayed an elevated 
risk for any BPD and the combined bipolar-I, bipolar-II category [both model 3 HR 7.9(1.8,34.6)]. 
These associations remained significant when effect of the severity of probands’ disorder, as 
represented by the GAF score, was considered (HR=7.4(1.1,51.9)). No evidence was found for 
increased mood disorder risk in offspring with late onset BPD probands 0.9(0.6,1.4). In addition, there 
was no evidence of increased risk of offspring MDD with BPD probands regardless of adjustment of 
covariates. Although there was an increase in risk of offspring mood disorder with early MDD 
10 
 
probands 1.9(1.0,3.5), the association was no longer significant after controlling for probands 
comorbid disorders 1.5(0.8,2.8).  
Regarding non-mood disorders, early onset proband BPD was significantly associated with the 
risk of offspring conduct disorder 3.0(1.0,8.6) and SUD 5.0(1.1,21.9), owing to the risk of alcohol 
abuse/dependence 7.9(1.4,45.0),  after adjusting for probands’ comorbid and spouses’ disorders. The 
later onset bipolar subtype in probands was not associated with an increased risk of any offspring 
disorder, except for offspring SAD in the unadjusted model 1.8(1.0,3.3). The offspring of probands’ 
with early MDD were found to be at an increased risk for anxiety disorders 2.6(1.3,5.2), SAD 
2.3(1.1,5.2) and behavioral disorders 2.4(1.1,5.0), but not after adjustments. The later onset MDD 
subtype in probands was associated with an increased risk of ADHD 2.1(1.0,4.4), but not after 
adjustments.  Finally, the later onset MDD subtype in probands was associated with an increased risk 
of SAD in all models [model 3 HR 2.4(1.2,4.9)].  
The exclusion of offspring of probands with bipolar schizoaffective disorders from analyses 
only marginally changed the results. The strong associations between early onset BPD in probands and 
any BPD (HR=9.0(1.9,43.0) p<.01), BPD (HR=9.0(1.9,43.0) p<.01), any SUD (4.6(1.1,19.6) p<.05) 
and alcohol abuse/dependence (5.5(1.0,30.1 p<.05) in offspring remained significant. Only the 
association between early onset BPD in probands and conduct disorder in offspring no longer reached 
the level of statistical significance (2.4(0.8; 6.8)).  
INSERT TABLE 3 HERE 
To test whether the chosen age of 21 years was an appropriate cut-off we conducted ROC 
analyses. This analysis revealed that age of onset of probands’ BPD was a better predictor than chance 
for determining the risk of offspring mania/hypomania (Area Under Curve = 0.72; 95% CI = 
0.60,0.84; p = 0.0004). The optimal age of onset was 20-21 years according to the sensitivity, 
specificity and total accuracy estimates. Similarly, the ROC curve analysis testing showed that age of 
onset was a better predictor than chance for determining the risk of MDD in offspring ( Area Under 
Curve = 0.57; 95% CI = 0.50,0.64; p = 0.0485). However, in contrast to BPD no clear delineation for 
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determining the optimal cut-off for the age of onset according to the sensitivity, specificity, and total 
accuracy estimates was observed. 
 
4.0. Discussion 
The present study provides the first evidence for an association between early age of onset of 
parental BPD or MDD and the incidence of mood and non-mood psychopathology in offspring during 
a follow-up period of more than 10 years. The most salient findings were: 1) the specificity of familial 
aggregation of BPD; and 2) the critical role of the age of onset of the parental disorder in the 
transmission of BPD. The highly specific transmission of BPD and the absence of evidence for shared 
familial risk between BPD and MDD confirms the results of our two recent family studies of adult 
relatives (Merikangas et al., 2014; Vandeleur et al., 2014), as well as those of twin studies of clinical 
samples (McGuffin et al., 2003).  Likewise, studies of treatment, course, and comorbidity have 
distinguished these two subtypes in both children and adults (Cuellar et al., 2005), and recent 
neuroimaging studies have indicated distinct neural architecture and function of BPD and MDD (Diler 
et al., 2013; Lan et al., 2014; Liang et al., 2013; Redlich et al., 2014). Taken together, these results 
provide strong evidence for the diagnostic separation of unipolar and bipolar mood disorders.  
Similar to prior high risk studies of BPD, we found an elevated risk of SUD, particularly 
alcohol use disorders, among offspring of probands with BPD, but not MDD. The prospective data 
demonstrating an increased risk of alcohol dependence among community adults with BPD 
(Merikangas et al., 2008) highlight the potential benefit of prevention of alcohol dependence through 
intervention in youth with early manifestations of BPD. The other non-affective disorder associated 
with parental BPD was childhood SAD, replicating the findings of an earlier prospective community 
study of youth (Bruckl et al., 2007) which found a 7-fold increased risk of BPD among youth with 
earlier SAD. We also found a more than two-fold increased risk of early SAD in youth of parents with 
MDD, which again replicates the findings of the prospective community study, even if this association 
did not reach statistical significance in the latter study. Future studies of this association are necessary 
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to examine the specificity and potential explanation for the specific links between SAD and mood 
disorders that emerged in our study. 
Our findings of an increased incidence of mood disorders among parents with early onset BPD 
suggest that early onset BPD could also distinguish genetic and biologic factors that may be masked in 
current studies of the full range of ages of onset and subtypes of mood disorders. This is consistent 
with growing evidence that early age of onset distinguishes genetic forms of breast cancer (King et al., 
2003), colorectal cancer (Tanskanen et al., 2015), multiple sclerosis (Giacalone et al., 2015) and 
numerous other diseases. Parallel to other diseases, later onset disorders are more likely to have 
different genetic and environmental exposures than the early onset forms of these conditions. The 
importance of age of onset as the primary index of a more heritable form of BPD (Visscher et al., 
2001) was indicated by its persistence after we controlled for potential correlates of age of onset 
including severity of mood disorder and comorbidity, suggesting that age of onset may be the primary 
index of a more heritable subset of BPD. We could also show that our results were not affected by the 
inclusion of offspring of probands with bipolar schizoaffective disorder. Although our data are 
compatible with a distinct early onset bipolar subtype, the findings remain limited by the relatively 
young age of the cohort at last interview that precludes our ability to study the specificity of both early 
and late onset forms of mood disorders. In particular, offspring of probands with the later onset BPD 
subtype may still develop mania/hypomania further on in life, and provide evidence for the familial 
aggregation of later onset BPD possibly with its own specific mechanisms. Future follow-up will be 
critical to our completing the full portrait of age of onset of BPD and MDD across the life span. 
In contrast to BPD, irrespective of the parental age of onset, there was no increase in MDD 
over the 10 years of follow-up. Although this finding apparently fails to confirm numerous earlier high 
risk studies of MDD cited above, our study is the largest to date that included parent proband groups 
of both  BPD and MDD, a larger well-characterized group of co-parents, and a comparable medically 
ill control group that may have led to differences in the findings regarding specificity of parental-
offspring MDD. As noted above, future increases in the incidence of MDD could distinguish offspring 
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of proband parents with MDD from controls. Alternatively, the lack of difference in risk between 
offspring of depressive probands and those of controls might have been attributable to the relatively 
high incidence of depressive symptoms/disorders among the adolescent offspring of controls. Finally, 
the generally lower heritability of MDD relative to that of BPD (Merikangas et al., 2014) may also 
contribute to this negative finding. 
There are several limitations that should be considered in interpreting our findings. First, 
although our study is the largest to date that included offspring of parent proband groups of both BPD 
and MDD, type II error cannot be ruled out because of the limited sample size. In particular, the power 
to detect an association for BPD was very limited given the rarity of the disorder in offspring. 
However, given the very strong association we have observed between parental early-onset BPD and 
the risk of BPD in offspring, the power of our analyses was still sufficient to detect this association. 
Second, although we minimized offspring recall bias by prospectively assessing ages of onset, the age 
of onset in probands was obtained retrospectively. Third, despite our efforts to directly interview all 
offspring across all assessments, almost a quarter of the assessments were derived from family history 
reports, similar to other prospective studies of adolescents. Fourth, although offspring were assessed 
every three years, the information collected for the interval of time between evaluations was 
necessarily retrospective. Fifth, the ages of onset in co-parents could not be adequately tested based on 
information from the family history reports for those who were not interviewed. 
Despite these limitations, we present the first high risk study that assesses simultaneously the 
specificity of familial transmission of both BPD and MDD and non-mood psychopathology and the 
effect of age of onset in offspring across more than a decade of follow-up. These findings have 
significant clinical and scientific implications. The offspring of parents with early onset BPD deserve 
particular clinical attention during adolescence when preventive efforts may reduce progression and 
consequences of this disorder. The confirmation of the independent familial transmission of BPD and 
MDD further emphasizes the need for diagnostic distinction between these subgroups in genetic 
studies, particularly in light of differences in the heritability of mania and depression. This is 
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especially pertinent in molecular genetic studies that are currently comprised of heterogeneous 
samples of probands with the full spectrum of bipolar disorder. Our data also provide compelling 
evidence that the early onset BPD subtype is a promising phenotype for such studies. Up to now, 
molecular genetic studies on the early onset subtype of BPD have encountered methodological 
problems including limited statistical power, varying ages of onset, inclusion of subjects with bipolar-
II disorder and varying criteria for selecting affected families, which have hindered the progress of this 
research (Kennedy et al., 2015). Future studies should therefore make efforts to standardize 
methodology and particularly use consistent definitions of early and later onset BPD (Kennedy et al., 
2015). Finally, future prospective high risk research that follows offspring across adulthood is also 
warranted to further determine the relationship between the early and later onset BPD phenotypes.  
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Table 1: Sample characteristics 
 
Probands (n=208) Probands with BPD (n=81) Probands with MDD (n=64) Control probands (n=63) Statistic p value Pairwise  
Female, % 58.0 56.3 44.4 Χ22=2.9 n.s. - 
Age at baseline, mean (s.d.) 40 (6.7) 41 (7.6) 41 (6.8) F2=0.3 n.s. - 
Married, % 61.7 57.8 77.8 Χ22=6.4 <0.05 AB 
Number of offspring included, mean (s.d.) 1.8 (0.9) 1.8 (0.8) 1.8 (0.8) F2=0.0 n.s. - 
Proband comorbidity 
Anxiety disorder*, % 29.6 45.3 6.4 Χ22=24.6 <0.001 AB 
Substance use disorder§, % 39.5 48.4 12.7 Χ22=19.7 <0.001 AB 
Any behavioral disorder+, % 19.8 21.9 7.9 Χ22=5.2 n.s. - 
SES of the family, mean (s.d.) 3.2 (1.0) 2.8 (1.0) 3.4 (1.0) F2=6.3 <0.01 BC 
Offspring (n=372) Offspring of BPD (n=145) Offspring of MDD (n=115) Offspring of CTRLS (n=112)    
Female, % 51.0 51.3 45.5 Z2=0.8 n.s. - 
Age at first assessment, mean (s.d.) 10.4 (4.3) 10.1 (3.8) 9.3 (4.8) F2=0.5 n.s. - 
Age at last assessment, mean (s.d.) 21.1 (5.6) 19.5 (5.2) 21.0 (5.9) F2=3.1 <0.05 BC 
Number of assessments, mean (s.d.) 4.3 (1.3) 3.8 (1.1) 4.6 (1.3) F2=7.4 <0.001 ABC 
Number of interviews, mean (s.d.) 3.3 (1.5) 2.9 (1.2) 3.3 (1.4) F2=1.8 n.s. - 
 
 
Key: BPD=bipolar disorder; MDD=major depressive disorder; CTRLS=controls; *includes generalized anxiety disorder, social phobia, panic disorder and/or agoraphobia;  
§ includes alcohol and drug abuse or dependence; + includes disruptive behavioral disorders and attention-deficit hyperactivity disorder; SES=socio-economic status. Pairwise 
comparisons: A: BPD vs. CTRL; B: MDD vs. CTRL; C: BPD vs. MDD. 
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Table 2: Rates (%) and risk (HR, 95 CI) of lifetime psychiatric disorders in offspring (N=372) by proband mood disorder 
  Proband disorder   
 BPD MDD Other
1
 
 Offspring N 145 115 112 
 
 
  Model 1 Model 2 Model 3   Model 1 Model 2 Model 3   
 Offspring disorder % HR HR HR % HR HR HR % 
     95 CI 95 CI 95CI   95 CI 95 CI 95CI   
 Any mood disorder 62.8 1.0 0.9 0.9 67.8 1.4 1.2 1.2 60.7 
 
 
  (0.7,1.6) (0.6,1.4) (0.6,1.5)   (0.9,2.3) (0.7,2.0) (0.7,2.2)   
    Any BPD 17.2 5.4* 3.4 2.8 7.0 1.7 0.7 0.7 4.5 
 
 
  (1.3,21.6) (0.7,16.2) (0.6,12.7)   (0.3,8.6) (0.1,4.9) (0.1,4.7)   
       BPD 12.4 5.4* 3.4 2.8 4.4 1.7 0.7 0.7 3.6 
   (1.3,21.6) (0.7,15.8) (0.6,12.9)   (0.3,8.6) (0.1,4.9) (0.1,4.7)   
      OSBARD
2
 4.8 .- .- .- 2.6 .- .- .- 0.9 
   .- .- .-   .- .- .-   
    Depressive spectrum 45.5 0.7 0.7 0.7 60.9 1.2 1.2 1.3 56.3 
 
 
  (0.5,1.1) (0.4,1.1) (0.4,1.1)   (0.8,2.0) (0.7,2.0) (0.7,2.2)   
       MDD 36.6 1.0 0.8 0.9 46.1 1.5 1.2 1.3 37.5 
   (0.6,1.6) (0.5,1.4) (0.5,1.5)   (0.9,2.6) (0.7,2.3) (0.7,2.5)   
       Dysthymia 1.4 .- .- .- 1.7 .- .- .- 2.7 
   .- .- .-   .- .- .-   
       OSDD
2
 7.6 0.5 0.6 0.6 13.0 1.0 1.2 1.3 16.1 
   (0.2,1.2) (0.2,1.4) (0.2,1.6)   (0.4,2.2) (0.5,3.2) (0.4,3.7)   
 Anxiety disorders
3
 43.5 1.4 1.2 1.2 41.7 1.3 1.0 1.0 38.4 
 
 
  (0.8,2.2) (0.7,2.0) (0.7,2.0)   (0.8,2.2) (0.6,1.8) (0.5,1.9)   
 Separation anxiety 40.7 1.9* 1.7 1.7 53.9 2.9*** 2.3* 2.4* 26.8 
 
 
  (1.1,3.3) (0.9,2.9) (0.9,3.0)   (1.6,5.1) (1.2,4.3) (1.2,4.6)   
 Any behavioral disorder 31.0 1.4 1.3 1.3 37.4 1.8 1.7 1.7 25.9 
 
 
  (0.8,2.4) (0.7,2.3) (0.7,2.4)   (1.0,3.2) (0.9,3.2) (0.9,3.4)   
    Conduct 11.7 1.1 1.1 1.1 11.3 1.1 1.2 1.2 11.6 
   (0.5,2.5) (0.5,2.6) (0.5,2.6)   (0.4,2.7) (0.4,3.1) (0.4,3.4)   
    ODD 14.5 1.3 1.3 1.2 17.4 1.6 1.6 1.7 13.4 
   (0.6,2.8) (0.6,3.0) (0.5,3.0)   (0.7,3.7) (0.6,4.0) (0.6,5.0)   
    ADHD 16.6 1.5 1.4 1.4 22.6 2.1* 1.9 1.9 13.4 
   (0.8,2.8) (0.7,2.7) (0.6,2.9)   (1.1,4.2) (0.9,4.1) (0.8,4.4)   
 Any substance disorder 27.6 2.4 2.2 2.1 28.7 2.9* 2.5 2.4 18.8 
 
 
  (1.0,5.7) (0.9,5.6) (0.8,5.6)   (1.1,7.9) (0.8,7.7) (0.8,7.8)   
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   Alcohol abuse/dependence 15.9 1.9 2.0 2.7 15.7 2.6 2.8 3.9 10.7 
   (0.7,5.3) (0.7,5.9) (0.7,10.5)   (0.8,8.1) (0.8,9.8) (0.8,17.7)   
    Drug abuse/dependence 18.6 2.3 1.6 1.3 20.0 2.6 1.4 1.2 13.4 
     (0.8,6.7) (0.6,4.4) (0.4,3.8)   (0.8,8.3) (0.4,4.8) (0.3,4.8)   
                 
*p<.05; **p<.01; ***p<.001. 
HR (hazard ratios); 95 CI (95% confidence intervals); BPD (bipolar disorder); OSBARD (Other Specified Bipolar and Related Disorders); 
MDD (major depressive disorder); OSDD (Other Specified Depressive Disorders); ODD (oppositional defiant disorder);   
ADHD (attention-deficit/hyperactivity disorder); substance abuse/dependence (DSM-IV criteria). 
    
Model 1: adjusted for sex, age and number of information points in offspring, proband age, socio-economic status of the family and within-family correlations;  
Model 2: Model 1 + adjusted for proband comorbid disorders (substance abuse/dependence, anxiety disorders, behavioral disorders); 
Model 3: Model 2 + adjusted for spouse mood disorders (bipolar and unipolar) and spouse comorbid disorders (substance abuse/dependence, 
anxiety and behavioral disorders). 
Models could not be calculated to assess the risk of OSBARD and dysthymia in offspring due to the low proportion of affected offspring. 
    
1 
This category includes offspring of probands with either no disorder or with subthreshold BPD, hyperthymic personality, subthreshold depression,  
anxiety disorders, as well as alcohol or drug abuse; 
2
 Includes information from interviews only; 
3
 Includes generalized anxiety disorder, agoraphobia, panic disorder and social phobia. 
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Table 3: Rates (%) and risk (HR, 95 CI) of lifetime psychiatric disorders in offspring (N=372) by proband mood disorder subtype 
 
 
  Proband disorder 
BPD subtypes MDD subtypes Other
1
 
Onset BPD <21 yrs Onset BPD >21 yrs Onset MDD <21 yrs Onset MDD > 21yrs 
Offspring N 52 93 36 79 112 
  Model 1 Model 2 Model 3   Model 1 Model 2 Model 3   Model 1 Model 2 Model 3   Model 1 Model 2 Model 3 
 Offspring disorder % HR HR HR % HR HR HR % HR HR HR % HR HR HR % 
    95 CI 95 CI 95 CI   95 CI 95 CI 95 CI   95 CI 95 CI 95 CI   95 CI 95 CI 95 CI 
Any mood disorder 65.4 1.3 1.1 1.1 61.3 0.9 0.8 0.8 80.6 1.9* 1.5 1.6 62.0 1.2 1.0 1.1 60.7 
 
  (0.7,2.2) (0.6,1.9) (0.6,2.0)   (0.6,1.4) (0.5,1.3) (0.5,1.3)   (1.0,3.5) (0.8,2.8) (0.8,3.1)   (0.7,2.1) (0.6,1.8) (0.6,1.9) 
   Any BPD 26.9 15.3*** 7.9* 7.9** 11.8 2.3 1.8 1.4 8.3 4.5 2.3 1.3 6.3 1.0 0.6 0.8 4.5 
 
  (3.3,70.2) (1.6,39.1) (1.8,34.6)   (0.5,9.9) (0.4,8.3) (0.3,6.1)   (0.7,29.1) (0.3,16.8) (0.1,10.9)   (0.2,7.1) (0.1,4.7) (0.1,6.2) 
      BPD 21.2 15.3*** 7.9* 7.9** 7.5 2.3 1.8 1.4 8.3 4.5 2.3 1.3 2.5 1.0 0.6 0.8 3.6 
  (3.3,70.2) (1.6,39.1) (1.8,34.6)   (0.5,9.9) (0.4,8.3) (0.3,6.1)   (0.7,29.1) (0.3,16.8) (0.1,10.9)   (0.2,7.1) (0.1,4.7) (0.1,6.2) 
     OSBARD
2
 5.8 .- .- .- 4.3 .- .- .- 0.0 .- .- .- 3.8 .- .- .- 0.9 
  .- .- .-   .- .- .-   .- .- .-   .- .- .- 
   Depressive spectrum 38.5 0.6 0.6 0.6 49.5 0.8 0.7 0.8 72.2 1.5 1.4 1.6 55.7 1.1 1.0 1.1 56.3 
 
  (0.3,1.1) (0.3,1.1) (0.3,1.1)   (0.5,1.2) (0.5,1.2) (0.5,1.3)   (0.8,2.8) (0.7,2.7) (0.8,3.4)   (0.7,1.8) (0.6,1.8) (0.6,2.0)   
      MDD 28.9 0.8 0.6 0.6 40.9 1.1 0.9 1.0 55.6 1.9 1.5 1.7 41.8 1.3 1.0 1.1 37.5 
  (0.4,1.5) (0.3,1.3) (0.3,1.3)   (0.6,1.8) (0.5,1.6) (0.6,1.7)   (0.9,3.8) (0.7,3.2) (0.8,3.6)   (0.8,2.4) (0.5,1.9) (0.6,2.0) 
      Dysthymia 0.0 .- .- .- 2.2 .- .- .- 2.8 .- .- .- 1.3 .- .- .- 2.7 
  .- .- .-   .- .- .-   .- .- .-   .- .- .- 
      OSDD
2
 9.6 0.6 0.7 0.8 6.5 0.5 0.5 0.5 13.9 1.0 1.1 1.4 12.7 1.0 1.3 1.3 16.1 
  (0.2,1.9) (0.2,2.3) (0.2,2.6)   (0.2,1.3) (0.2,1.5) (0.2,1.6)   (0.3,3.2) (0.3,4.0) (0.3,5.7)   (0.4,2.7) (0.5,3.7) (0.4,4.0) 
Anxiety disorders
3
 40.4 1.3 1.1 1.0 45.2 1.4 1.3 1.3 61.1 2.6** 2.0 2.2 32.9 0.9 0.7 0.7 38.4 
 
  (0.7,2.5) (0.5,2.2) (0.5,2.1)   (0.8,2.4) (0.7,2.2) (0.7,2.3)   (1.3,5.2) (0.9,4.4) (0.9,5.0)   (0.5,1.6) (0.4,1.4) (0.3,1.4) 
Separation anxiety 44.2 2.1* 1.8 1.7 38.7 1.8* 1.6 1.6 50.0 2.3* 2.0 2.2 55.7 3.1*** 2.4* 2.4* 26.8 
 
  (1.1,4.3) (0.9,3.7) (0.8,3.6)   (1.0,3.3) (0.9,3.0) (0.9,3.1)   (1.1,5.2) (0.9,4.7) (0.9,5.4)   (1.7,5.8) (1.2,4.8) (1.2,4.9) 
Any behavioral disorder 36.5 1.7 1.5 1.6 28.0 1.2 1.2 1.1 44.4 2.4* 2.3* 2.1 34.2 1.6 1.4 1.6 25.9 
 
  (0.9,3.3) (0.8,3.1) (0.8,3.3)   (0.7,2.2) (0.6,2.1) (0.6,2.1)   (1.1,5.0) (1.0,5.1) (0.9,5.0)   (0.8,2.9) (0.7,2.8) (0.8,3.1) 
   Conduct 17.3 2.0 2.4 3.0* 8.6 0.7 0.8 0.7 11.1 1.2 1.9 1.2 11.4 1.0 1.1 1.5 11.6 
  (0.8,5.0) (0.9,6.7) (1.0,8.6)   (0.3,1.7) (0.3,2.0) (0.3,1.9)   (0.4,4.1) (0.5,7.3) (0.2,6.0)   (0.4,2.5) (0.4,3.1) (0.5,4.3) 
   ODD 17.3 1.5 1.5 1.7 12.9 1.2 1.2 1.0 22.2 2.0 2.1 1.8 15.2 1.4 1.4 1.7 13.4 
  (0.5,4.1) (0.5,4.1) (0.6,5.2)   (0.5,2.8) (0.5,2.8) (0.4,2.6)   (0.7,5.9) (0.7,6.6) (0.5,6.6)   (0.6,3.6) (0.5,3.6) (0.6,5.1) 
   ADHD 21.2 1.8 1.5 1.5 14.0 1.3 1.1 1.1 25.0 2.2 2.0 1.9 21.5 2.1* 1.8 1.7 13.4 
  (0.8,4.1) (0.7,3.7) (0.6,3.6)   (0.6,2.7) (0.5,2.5) (0.5,2.4)   (0.9,5.4) (0.8,5.2) (0.7,5.1)   (1.0,4.4) (0.8,4.1) (0.7,4.0) 
Any substance disorder 25.0 4.4* 3.9* 5.0* 29.0 1.7 1.7 1.6 22.2 3.1 3.1 3.9 31.7 2.6 2.6 2.8 18.8 
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  (1.4,13.8) (1.1,14.3) (1.1,21.9)   (0.7,4.1) (0.6,4.5) (0.6,4.5)   (0.8,12.1) (0.7,14.2) (0.7,23.9)   (1.0,7.2) (0.8,8.6) (0.7,10.8) 
  Alcohol 
abuse/dependence 15.4 4.9 5.2 7.9* 16.1 1.3 1.4 1.8 11.1 3.2 3.3 5.1 17.7 2.9 3.4 4.4 10.7 
  (0.9,26.1) (1.0,27.0) (1.4,45.0)   (0.4,4.3) (0.4,4.7) (0.5,6.7)   (0.5,18.8) (0.5,20.5) (0.7,38.3)   (0.8,11.0) (0.8,14.3) (0.9,21.5) 
   Drug 
abuse/dependence 17.3 4.4* 2.4 3.0 19.4 1.6 1.3 1.0 13.9 2.8 1.9 1.7 22.8 2.5 1.4 1.3 13.4 
    (1.2,16.1) (0.6,9.5) (0.6,15.1)   (0.5,4.8) (0.5,3.7) (0.3,3.0)   (0.5,15.1) (0.4,9.7) (0.2,12.7)   (0.8,8.3) (0.4,4.9) (0.3,6.0)   
 
          
*p<.05; **p<.01; ***p<.001. 
HR (hazard ratios); 95 CI (95% confidence intervals); 
BPD (bipolar disorder); OSBARD (Other Specified Bipolar and Related Disorders); MDD (major depressive disorder); OSDD (Other Specified Depressive Disorders); 
ODD (oppositional defiant disorder); ADHD (attention-deficit/hyperactivity disorder); substance abuse/dependence (DSM-IV criteria). 
        
Model 1: adjusted for sex, age and number of information points in offspring, proband age, socio-economic status of the family and within-family 
correlations; 
Model 2: Model 1 + adjusted for proband comorbid disorders (substance abuse/dependence, anxiety disorders, behavioral disorders); 
Model 3: Model 2 + adjusted for spouse mood disorders (bipolar and unipolar) and spouse comorbid disorders (substance abuse/dependence, anxiety disorders, 
behavioral disorders). 
Models could not be calculated to assess the risk of OSBARD and dysthymia in offspring due to the low proportion of affected offspring.  
1 
This category includes offspring of probands with either no disorder or with subthreshold BPD, hyperthymic personality, subthreshold depression, anxiety disorders, as 
well as alcohol or drug abuse; 
2
 Includes information from interviews only; 
3
 Includes generalized anxiety disorder, agoraphobia, panic disorder and social phobia. 
